December 2017

December 2017

Welcome to the December issue of The Ophthalmologist! Upfront’s topics include the brolucizumab HAWK and HARRIER trial results, and a potential new therapeutic for uveal melanoma. In My View sees Richard Lindstrom focus on driving innovation in the ophthalmic space, and Jesse Berry shares how they’re tackling the challenge of improving retinoblastoma care. In our Feature, The Innovators 2017, some of the leaders in the field showcase their latest and greatest technologies. In Practice sees Elizabeth Yeu discuss how ophthalmologists can combat the modern dry eye epidemic. In NextGen, Michael O’Rourke addresses how sustained drug delivery devices can make it to market, and Alex Huang shares the latest updates on his aqueous angiography work. In Profession, Pablo Artal recommends an optics refresh. Finally, we Sit Down With Chelvin Sng, Consultant Ophthalmologist at National University Hospital, Singapore.